VisMederi Sara Pugliese

VisMederi: a new anti Covid vaccine made in Italy

09 Oct 2021

A new candidate vaccine against Covid-19 to be administered without a needle. It is called LeCoVax2 and, both for its mechanism of action and for its characteristics, it represents an absolute novelty in the battle against Sars-CoV-2. VisMederi and University of Milan have...

Leggi/Read →

CGTN’s video reportage on VisMederi: “At the forefront in Italy and in the world”

07 Oct 2021

HERE FOR THE ARTICOLE https://www.vismederi.com/cgtns-video-reportage-on-vismederi-at-the-forefront-in-italy-and-in-the-world/

Leggi/Read →

CGTN’s reportage on VisMederi: “At the forefront in Italy and in the world”

07 Oct 2021

“Among the rolling hills of Tuscany, you can find the laboratories that are at the forefront of the research on the origins of Covid-19 in Italy and in the world”. Thus, the Chinese English-speaking broadcaster CGTN (China Global Television Network) spoke about VisMederi in a...

Leggi/Read →

VisMederi Research Partner of the PANVIR.NET Project

19 Aug 2018

Recent demographic and climatic changes have led to a greater spread of arboviruses such as Dengue, Chikungunya, Zika, West Nile and new influenza virus subtypes, as well as to an increased risk of new infections or reactivation of persistent ones, including herpes infections...

Leggi/Read →

VisMederi Research: good results for “INSIDE” research project.

11 Oct 2017

The project, in which VisMederi Research is a partner, is aimed at developing diagnostic and theranostic targeting based on nanosystems and/or engineered lymphocytes for the early detection and treatment of melanoma, and multiple sclerosis. With its participation in the INSIDE...

Leggi/Read →

VisMederi’s expertise in meningitidis is growing also with opinions from Dr. Rino Rappuoli.

22 May 2017

“An unwanted guest: Neisseria meningitides – carriage, risk for invasive disease and the impact of vaccination with insights from Italy incidence”. Gianchecchi E1, Piccini G1,2, Torelli A1,2, Rappuoli R3, Montomoli E1,4. Invasive Meningococcal Disease (IMD)...

Leggi/Read →

New research on Toscana Virus in collaboration between University of Siena and VisMederi srl

01 Mar 2017

“Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy”. Marchi S, Trombetta CM, Kistner O, Montomoli E. Sandfly fever viruses are transmitted by the bite of phlebotomine sandflies;...

Leggi/Read →

VisMederi is research partner in the ADITEC Project – 2016 Annual Meeting in Brussels and event at the European Parliament.

09 Nov 2016

VisMederi will be present also this year at the Annual Meeting of ADITEC project to be held in Brussels on November 7 to 9 in 2016. ADITEC (Advanced Immunization Technologies) is a five-year project that began in 2011 thanks to the collaboration of scientists from 13 countries...

Leggi/Read →

Prof. Montomoli at EDUFLUVAC Annual Meeting 2016 – Towards the Development of a Vaccine against “Universal” Flu

24 Oct 2016

Emanuele Montomoli, CSO of VisMederi and Professor of Public Health at the University of Siena, will take part as a member of the Scientific Committee at EDUFLUVAC Annual Meeting 2016 to be held in Zurich on 20 and 21 October 2016. EDUFLUVAC is a four-year cooperation project...

Leggi/Read →

VisMederi in Barcelona for the 2016 World Vaccine Congress

24 Oct 2016

As usual, VisMederi will be present this year too at the World Vaccine Congress, the leading event in Europe in the field of vaccines, now at its 17th edition, to be held in Barcelona October 10 to 12, 2016. The Congress will discuss the ongoing works in the vaccine field, with...

Leggi/Read →

12 3 4 5

By

VisMederi: a new anti Covid vaccine made in Italy

CGTN’s video reportage on VisMederi: “At the forefront in Italy and in the world”

CGTN’s reportage on VisMederi: “At the forefront in Italy and in the world”

VisMederi Research Partner of the PANVIR.NET Project

VisMederi Research: good results for “INSIDE” research project.

VisMederi’s expertise in meningitidis is growing also with opinions from Dr. Rino Rappuoli.

New research on Toscana Virus in collaboration between University of Siena and VisMederi srl

VisMederi is research partner in the ADITEC Project – 2016 Annual Meeting in Brussels and event at the European Parliament.

Prof. Montomoli at EDUFLUVAC Annual Meeting 2016 – Towards the Development of a Vaccine against “Universal” Flu

VisMederi in Barcelona for the 2016 World Vaccine Congress

Work with us

Privacy

Whistleblowing

TAMPONI COVID-19

PRESTAZIONI DIAGNOSTICHE

Search

Contact

Laboratories

Headquarter